Cyclopamine is a novel hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1417-1421

  Che, Jun ^a,b   Zhang, Fu Zheng ^b   Zhao, Chao Qian ^a   Hu, Xu Dong ^a   Fan, Sai Jun ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Soochow University   (China)

Author keywords

Breast cancer; Cyclopamine; Estrogen receptor ; Invasion; MAPK ERK; Proliferation

Indexed keywords

BETA ACTIN; CYCLIN D1; CYCLOPAMINE; ESTROGEN RECEPTOR ALPHA; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN G;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CELL CULTURE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN RESPONSIVE ELEMENT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PHASE CONTRAST MICROSCOPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 84874444363     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1195     Document Type: Article

References (13)

1. Ginsburg OM and Love RR: Breast cancer: a neglected disease for the majority of affected women worldwide. Breast J 3: 289-295, 2011.
2. McDermott SP and Wicha MS: Targeting breast cancer stem cells. Mol Oncol 5: 404-419, 2010.
3. Laxmi Y, Elegbedea JA and Carpera SW: Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells. Anticancer Drugs 8: 766-776, 2008.
4. Shibani M, Natalya F, Andrea S, et al: Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther 6: 674-683, 2006.
5. Kumara S, Indrajit R, Anchooria RK, et al: Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer. Bioorg Med Chem 6: 2764-2768, 2008.
6. Bara EE, Chaudhrya A, Lina A, et al: Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 10: 2524-2533, 2007.
7. Li XL, Meng QH, Fan SJ, et al: Adenovirus-mediated expression of UHRF1 reduces the radiosensitivity of cervical cancer HeLa cells to gamma-irradiation. Acta Pharmacol Sin 4: 458-466, 2009.
8. Jiao Y, Ge CM, Meng QH, et al: Adenovirus-mediated expression of Tob1 sensitizes breast cancer cells to ionizing radiation. Acta Pharmacol Sin 10: 1628-1636, 2007.
9. Jiao Y, Ge CM, Meng QH, et al: Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacol Sin 7: 1045-1056, 2007.
10. Somesh B and Alahari SK: miRNA control of tumor cell invasion and metastasis. Int J Cancer 6: 1283-1290, 2010.
11. Nguyena HH, Lavrenovc SN, Sundara SN, et al: 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells. Chem Biol Interact 3: 255-266, 2010.
12. Chen L, Mayer JA, Krisko TI, et al: Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Res 23: 8853-8861, 2009.
13. Li MW, Mruk DD, Cheng CY, et al: Mitogen-activated protein kinases in male reproductive function. Trends Mol Med 15: 159-168, 2009.